Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Payables (2023 - 2025)

BrightSpring Health Services (BTSG) has disclosed Payables for 3 consecutive years, with $1.2 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Payables rose 31.82% year-over-year to $1.2 billion, compared with a TTM value of $1.2 billion through Dec 2025, up 31.82%, and an annual FY2025 reading of $1.2 billion, up 31.82% over the prior year.
  • Payables was $1.2 billion for Q4 2025 at BrightSpring Health Services, up from $954.5 million in the prior quarter.
  • Across five years, Payables topped out at $1.2 billion in Q4 2025 and bottomed at $641.6 million in Q4 2023.
  • Average Payables over 3 years is $853.4 million, with a median of $868.1 million recorded in 2025.
  • Peak annual rise in Payables hit 44.2% in 2025, while the deepest fall reached 21.77% in 2025.
  • Year by year, Payables stood at $641.6 million in 2023, then soared by 44.0% to $923.9 million in 2024, then skyrocketed by 31.82% to $1.2 billion in 2025.
  • Business Quant data shows Payables for BTSG at $1.2 billion in Q4 2025, $954.5 million in Q3 2025, and $965.3 million in Q2 2025.